INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 417m ago
House PTR16m ago
SEC 13F16m ago
Robinhood Chain16m ago

Results

77,304 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
DA
Dhanda AnujChief Tech &Transformation Off
ACIAlbertsons Companies, Inc.
Option exercise
M—
24.5K sh
Apr 21, 2026Apr 23, 2026
Page 1088 of 1933
← PrevNext →
traded Apr 21, 2026
+2d
SEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
15.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
116.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
162.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
GW
Grossman WilliamDirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
22.5K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
72.7K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
PM
Peterson MichaelEXECUTIVE VICE PRESIDENT
SEICSEI INVESTMENTS CO
Option exercise
M—
10.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

8
WR
Wills Phillip R. IIIDirector
FVCBFVCBankcorp, Inc.
Option exercise
M$198K
21.5K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

8
BE
Bertels Mark E.EVP - Risk Management Services
CRVLCORVEL CORP
Option exercise
M$60K
1,050 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$100K
8,254 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$64K
5,503 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$65K
5,443 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

5
SR
Stangl RolfDirector
REYNReynolds Consumer Products Inc.
Option exercise
M—
9,322 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

5
WL
Whitley Laura LDirector
TCBITEXAS CAPITAL BANCSHARES INC/TX
Option exercise
M—
1,670 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

5
WR
Wills Phillip R. IIIDirector
FVCBFVCBankcorp, Inc.
Grant or award
A—
2,000 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

5
BE
Bertels Mark E.EVP - Risk Management Services
CRVLCORVEL CORP
Tax withholding
F$5,396
94 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

4
EM
Erlinger Joseph M.President, McDonald's USA
MCDMCDONALDS CORP
Open-market sale · 10b5-1 plan
SELL$101K
333 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

4
KK
Keough KelliEVP, GBUL, SIPS
SOFISoFi Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$188K
9,742 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

4
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$202K
2,850 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

2
AI
Aoki IchiroDirector, President
INDIindie Semiconductor, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
6,500 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

1
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M$258K
10.0K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

0
AI
Aoki IchiroDirector, President
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
6,500 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

0
PF
Parslow James FInterim CEO and CFO
XBIOXenetic Biosciences, Inc.
Grant or award · 10b5-1 plan
A—
100.0K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
107.7K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

0
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M—
400 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
107.7K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

0
CN
Chandhok NikhilChief Product & Tech. Officer
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M—
10.0K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

0
AI
Aoki IchiroDirector, President
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
6,500 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

0
AI
Aoki IchiroDirector, President
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
6,500 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

0
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M$344
400 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

53
JR
Jeffrey John Ronald Jr.Director
AGXARGAN INC
Open-market sale
SELL$2.24M
3,636 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

49
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Open-market sale
SELL$1.52M
2,500 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

49
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Open-market sale
SELL$6.88M
11.1K sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

48
GH
GIP ATLAS Holdings Ltd10% Owner
HTOH2O AMERICA
Open-market purchase
BUY$2.98M
50.4K sh
Apr 10, 2026Apr 22, 2026
traded Apr 10, 2026
+12dSEC Form 4

Evidence

47
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$12.46M
106.3K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

47
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$49.84M
425.1K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

45
GC
Gillespie CharlesDirector, CEO
GAMBGRANDSTAND Ltd
Open-market purchase
BUY$13K
3,860 sh
Apr 15, 2026Apr 22, 2026
traded Apr 15, 2026
+7dSEC Form 4

Evidence

45
ME
Mark Martin EliasCFO
GAMBGRANDSTAND Ltd
Open-market purchase
BUY$13K
3,860 sh
Apr 15, 2026Apr 22, 2026
traded Apr 15, 2026
+7dSEC Form 4

Evidence

45
MR
McCrystle Kevin RossDirector, COO
GAMBGRANDSTAND Ltd
Open-market purchase
BUY$2,391
738 sh
Apr 15, 2026Apr 22, 2026
traded Apr 15, 2026
+7dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.02M
25.8K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence